Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression
Frontiers in Cell and Developmental Biology · 12.03.2025 · 13
DOI: 10.3389/fcell.2025.1489958 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.03.2025. Verfasst von Jiaying Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Basic Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nicotinic acetylcholine receptors (nAChRs) are widely expressed in a variety of cell types and are involved in multiple physiological regulatory mechanisms in cells, tissues and systems. Increasing evidence suggests that the α5 nicotinic acetylcholine receptor (α5-nAChR), encoded by the CHRNA5 gene, is one of a key mediator involved in lung cancer development and immune responses. Several studies have shown that it is a regulator that stimulates processes via various signaling pathways, including STAT3 in lung cancer. In addition, α5-nAChR has a profound effect on lung immune response through multiple immune-related factor pathways. In this review, we focus on the perspectives on α5-nAChR in lung cancer progression, which indicates that targeting α5-nAChR could provide novel anticancer and immune therapy strategies for lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center of Basic Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zitieren
APA
Cai, J., Wang, J., Wang, Z., Wang, J., Jia, Y., & Ma, X. (2025). Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1489958
Vancouver
Cai J, Wang J, Wang Z, Wang J, Jia Y, Ma X. Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1489958
BibTeX
@article{Cai2025,
author = {Cai, Jiaying and Wang, Jingting and Wang, Zengping and Wang, Jing and Jia, Yanfei and Ma, Xiaoli},
title = {Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1489958}
}
EUVIMED